Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition

Journal of Hypertension

Volumn 20, Issue 4, 2002, Pages 739-743

  Berger, Elke D ^a   Bader, Birgit D ^a   Ebert, Carola ^a   Risler, Teut ^a   Erley, Christiane M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Angiotensin receptor antagonist; Angiotensin converting enzyme inhibitor; Candesartan; Giomerulonephritis; Hypertension; IgA nephritis; Proteinuria; Renal hemodynamics; Renoprotection

Indexed keywords

4 AMINOHIPPURIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INULIN; QUINAPRIL; RAMIPRIL;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; INULIN CLEARANCE; KIDNEY CLEARANCE; KIDNEY PLASMA FLOW; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0036528791     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200204000-00033     Document Type: Article

References (24)

1. Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial
2. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
3. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
4. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
5. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
6. Impact of angiotensin II on the kidney: Does an angiotensin II receptor blocker make sense?
7. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
8. Serine protease angiotensin II systems
9. Plasma angiotensins and blood pressure during converting enzyme inhibition
10. Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases
11. Antihypertensive therapy with MK 421: Angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade
12. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats
13. The effects of the combination of valsartan, an Angiotensin II antagonist, plus benazepril, an ACEI, on renal function in the rat remnant kidney model
14. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy
15. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation
16. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats
17. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis
18. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy
19. Antiproteinuric effect of Losartan in patients with chronic renal diseases
20. Safety of the combination of valsartan and benazepril in patients with chronic renal disease
21. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension
22. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
23. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
24. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy